Akebia Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
01.04.25
/
50%
€1.85
Target price
01.04.26
€5.54
Performance (%)
-36.32%
End price
02.04.26
€1.18
Summary
This prediction ended on 02.04.26 with a price of €1.18. Massive losses of -36.32% were the result for the BUY prediction by Jefferies_Financial_. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 0.164% | 0.164% | -73.623% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by Jefferies_Financial_ for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten